We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01314677
Recruitment Status : Withdrawn (No subjects have been accrued to this trial. The PI will no longer be at COH and requests a study withdrawal/closure.)
First Posted : March 14, 2011
Last Update Posted : June 29, 2012
National Cancer Institute (NCI)
Information provided by (Responsible Party):
City of Hope Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : June 2012
  Study Completion Date : June 2012